Citigroup Maintains Buy on Attovia Therapeutics, Raises Price Target to $34
Morgan Stanley Maintains Overweight on Attovia Therapeutics, Raises Price Target to $40
Attovia Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update
Attovia Therapeutics Q3 EPS $(0.76) Misses $(0.50) Estimate
Attovia Therapeutics, Inc. (ATTO) Discusses ATTO-1310 Phase Ib Results in Chronic Pruritus and Atopic Dermatitis Transcript
Attovia Therapeutics Reports Sustained Itch Relief in Small Study, Plans Phase 2 Trials
Attovia Therapeutics Announces Positive Topline 12-Week Results from Phase 1b Study of ATTO-1310 in Patients with Chronic Pruritus and High-Itch Atopic Dermatitis
Attovia Therapeutics to Participate in Upcoming Investor Conferences
Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026
Attovia Therapeutics To Present New Clinical, Translational, And Preclinical Data Across Its Pipeline At EADV Congress And FCD 2026
Attovia Therapeutics (ATTO) Pulls Back As Investors Ask If The Valuation Still Fits
Attovia Therapeutics, Inc. (ATTO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
Attovia Therapeutics Q2 EPS $(4.88) Misses $(4.62) Estimate, Sales $450.000K
Attovia Therapeutics Could Serve as Key Player in Immunology, Inflammation, RBC Says
Citigroup Initiates Coverage On Attovia Therapeutics with Buy Rating, Announces Price Target of $30
LifeSci Capital Initiates Coverage On Attovia Therapeutics with Outperform Rating, Announces Price Target of $45
Leerink Partners Initiates Coverage On Attovia Therapeutics with Outperform Rating, Announces Price Target of $52
RBC Capital Initiates Coverage On Attovia Therapeutics with Outperform Rating, Announces Price Target of $45
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.